Obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota? M. Knaapen, R.S. Kootte, E.G. Zoetendal, W.M.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

L.H. Su, T.L. Wu, C.H. Chiu Clinical Microbiology and Infection

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-C. Lagier Clinical Microbiology and Infection

L. Boyanova Clinical Microbiology and Infection

The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection R. Singh, M. Nieuwdorp, I.J.M.

Gut bacterial microbiota and obesity

L.H. Su, T.L. Wu, C.H. Chiu Clinical Microbiology and Infection

Obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota? M. Knaapen, R.S. Kootte, E.G. Zoetendal, W.M.

Approach to diagnosis of infective endocarditis

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Changes in the intestinal microbiota from adulthood through to old age

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era T.I. Pedersen, M. Howitz, C. Østergaard Clinical.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Gut microbiota and non-alcoholic fatty liver disease: new insights

In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the.

J.-P. Van geertruyden Clinical Microbiology and Infection

David R. Meldrum, M. D. , Marge A. Morris, M. Ed. , R. D. , C. D. E

R. Cantón Clinical Microbiology and Infection

Genital Chlamydia trachomatis infections

P. Nordmann, L. Poirel Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Non-antibiotic strategies for sepsis

Surveillance of Legionnaires’ disease in Austria

Impact of antibiotic restrictions: the pharmaceutical perspective

Vector control: a cornerstone in the malaria elimination campaign

Nat. Rev. Nephrol. doi: /nrneph

Training for the infectious diseases speciality in Norway

Laboratory diagnosis and biosafety issues of biological warfare agents

Structural studies of lipid A from a lipopolysaccharide of the Coxiella burnetii isolate RSA 514 (Crazy) P. Vadovic, A. Fuleova, R. Ihnatko, L. Skultety,

Elements of design: the knowledge on which we build

Levofloxacin in the treatment of ventilator-associated pneumonia

G. Pappas Clinical Microbiology and Infection

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

Effect of antioxidants on the immune response of Helicobacter pylori

David R. Meldrum, M. D. , Marge A. Morris, M. Ed. , R. D. , C. D. E

Laboratory diagnosis of Clostridium difficile disease

The practice of travel medicine in Europe

T.M. File Clinical Microbiology and Infection

Update on antifungal resistance in Aspergillus and Candida

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

C. Tamalet, P. Colson, E. Decroly, C. Dhiver, I. Ravaux, A. Stein, D

Reducing antibiotic use in influenza: challenges and rewards

G.M. Rossolini, E. Mantengoli Clinical Microbiology and Infection

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Clinical Microbiology and Infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Survival of rhinoviruses on human fingers

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

Carratalà J. Clinical Microbiology and Infection

B.A. Cunha Clinical Microbiology and Infection

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota? M. Knaapen, R.S. Kootte, E.G. Zoetendal, W.M. de Vos, G.M. Dallinga-Thie, M. Levi, E.S. Stroes, M. Nieuwdorp Clinical Microbiology and Infection Volume 19, Issue 4, Pages 331-337 (April 2013) DOI: 10.1111/1469-0691.12170 Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Potential associations between the intestinal microbiota and obesity-related comorbidities, comprising insulin resistance, cardiovascular disease, venous thromboembolic events and non-alcoholic fatty liver disease (NAFLD). GMB, Gut microbiota; LPS, lipopolysaccharide; PAI-1, plasminogen activator inhibitor-1; SCFA, short-chain fatty acid; TMAO, trimethylamine-N-oxide. Clinical Microbiology and Infection 2013 19, 331-337DOI: (10.1111/1469-0691.12170) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions